Oncolytic Virus and Anti-4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
Liza B John, Linda J Howland, Jacqueline K Flynn, Alison C West, Christel Devaud, Connie P Duong, Trina J Stewart, Jenny A Westwood, Z Sheng Guo, David L Bartlett, Mark J Smyth, Michael H Kershaw, Phillip K Darcy
Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2012
This work was funded by Project Grants from the National Health and Medical Research Council (NHMRC), Cancer Council of Victoria, and the Susan Komen Breast Cancer Foundation. T.J. Stewart was supported by a National Breast Cancer Foundation Fellowship and M.J. Smyth by an NHMRC Australian Research Fellowship. M.H. Kershaw and P.K. Darcy were supported by a NHMRC Senior Research Fellowship and Career Development Award, respectively.